Type 2 diabetes
Conditions
Interventions
1:Acarbose
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Informed consent obtained before any trial-related activities; 2. Male or female, aged 18 to 75 years; 3. Subjects diagnosed with type 2 diabetes meeting the WHO criterion 1999; 4. On stable treatment in a period of 90 days prior to screening with pre-mix insulin without other oral anti-diabetics; 5. The duration of type 2 diabetes more than 5 years; 6. HbA1c 7.0-10.0%.
Exclusion criteria
Exclusion criteria: 1. Any acute diabetic complication in the past 6 months(including the severe hypoglycemia in the past 6 months with unexplained cause); 2. Known asymptomatic hypoglycemia or recurrent hypoglycemia; 3. Known hypersensitivity to trail product(s) or related products; 4. Any disorder which, in the opinion of the investigator, might be a barrier to compliance to the protocol; 5. Female who is pregnant, breast-feeding or intends to become pregnant; 6. History of mental disease; 7. Ongoing or previous participation in other clinical trial in the past 1 month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean Amplitude of Plasma Glucose Excursions; | — |
Countries
China
Contacts
Public ContactLixin Guo
Department of Endocrinology, Beijing Hospital
Outcome results
None listed